ATE531387T1 - Nahtlinien-verabreichungstechnik mit botulinustoxinen - Google Patents

Nahtlinien-verabreichungstechnik mit botulinustoxinen

Info

Publication number
ATE531387T1
ATE531387T1 AT09727789T AT09727789T ATE531387T1 AT E531387 T1 ATE531387 T1 AT E531387T1 AT 09727789 T AT09727789 T AT 09727789T AT 09727789 T AT09727789 T AT 09727789T AT E531387 T1 ATE531387 T1 AT E531387T1
Authority
AT
Austria
Prior art keywords
suture line
administration technique
line administration
botulinus
toxins
Prior art date
Application number
AT09727789T
Other languages
English (en)
Inventor
Andrew Blumenfeld
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of ATE531387T1 publication Critical patent/ATE531387T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A61K38/4893—Botulinum neurotoxin (3.4.24.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24069—Bontoxilysin (3.4.24.69), i.e. botulinum neurotoxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT09727789T 2008-04-03 2009-03-31 Nahtlinien-verabreichungstechnik mit botulinustoxinen ATE531387T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/062,372 US8617571B2 (en) 2008-04-03 2008-04-03 Suture line administration technique using botulinum toxin
PCT/US2009/038950 WO2009124046A1 (en) 2008-04-03 2009-03-31 Suture line administration technique using botulinum toxins

Publications (1)

Publication Number Publication Date
ATE531387T1 true ATE531387T1 (de) 2011-11-15

Family

ID=41016982

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09727789T ATE531387T1 (de) 2008-04-03 2009-03-31 Nahtlinien-verabreichungstechnik mit botulinustoxinen

Country Status (12)

Country Link
US (7) US8617571B2 (de)
EP (2) EP2392344B1 (de)
CN (1) CN102056620A (de)
AT (1) ATE531387T1 (de)
AU (1) AU2009231786B2 (de)
BR (1) BRPI0910993A2 (de)
CA (1) CA2720112C (de)
DK (1) DK2282766T3 (de)
ES (2) ES2372678T3 (de)
MX (1) MX2010010885A (de)
NZ (3) NZ600858A (de)
WO (1) WO2009124046A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7780967B2 (en) * 2000-02-08 2010-08-24 Allergan, Inc. Reduced toxicity Clostridial toxin pharmaceutical compositions
US6440312B1 (en) 2000-05-02 2002-08-27 Kai Technologies, Inc. Extracting oil and water from drill cuttings using RF energy
US20050191321A1 (en) * 2004-02-26 2005-09-01 Allergan, Inc. Methods for treating headache
US20100266638A1 (en) 2004-02-26 2010-10-21 Allergan, Inc. Headache treatment method
US9078892B2 (en) * 2004-02-26 2015-07-14 Allergan, Inc. Methods for treating pain and for treating a medication overuse disorder
US9211248B2 (en) 2004-03-03 2015-12-15 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
US7655244B2 (en) 2005-02-01 2010-02-02 Allergan, Inc. Targeted delivery of botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditions
US7749515B2 (en) 2005-02-01 2010-07-06 Allergan, Inc. Targeted delivery of botulinum toxin to the sphenopalatine ganglion
US8617571B2 (en) * 2008-04-03 2013-12-31 Allergan, Inc. Suture line administration technique using botulinum toxin
EP2512507A4 (de) * 2009-12-15 2013-04-17 Ira Sanders Behandlung von nasen- und brustleiden
US9764009B2 (en) * 2011-06-13 2017-09-19 Allergan, Inc. Treatment of psychological trauma
US9480731B2 (en) 2013-12-12 2016-11-01 Medy-Tox, Inc. Long lasting effect of new botulinum toxin formulations
CN105251041A (zh) * 2015-10-28 2016-01-20 钊桂英 一种纯天然胶原蛋白医用缝合线及制备方法
KR20240023684A (ko) 2016-09-13 2024-02-22 알레간 인코포레이티드 안정화된 비단백질 클로스트리듐 독소 조성물
US10932711B2 (en) 2017-02-27 2021-03-02 Payman Sadeghi Method and system for neurohydrodissection
EP3694587A4 (de) * 2017-10-12 2021-08-11 Leslie, Tufts Verfahren und vorrichtung zur injektion eines neurotoxins in einen lokalisierten bereich
AU2019299676A1 (en) 2018-07-05 2021-01-28 Allergan Pharmaceuticals International Limited Combination therapy with CGRP antagonists and Clostridial derivatives
WO2021005494A1 (en) 2019-07-05 2021-01-14 Allergan Pharmaceuticals International Limited Cgrp antagonists and clostridial derivatives for the treatment of neuropsychiatric and neurological disorders
WO2021005497A1 (en) 2019-07-05 2021-01-14 Allergan Pharmaceuticals International Limited Cgrp antagonists and clostridial derivatives for the treatment of cortical spreading depression associated disorders
US20210130445A1 (en) 2019-07-05 2021-05-06 Allergan Pharmaceuticals International Limited CGRP Antagonists and Botulinum Toxins for the Treatment of Inflammatory and Neurologic Disorders
WO2021247890A1 (en) * 2020-06-03 2021-12-09 Miotox, Llc Zonal and targeted methods and uses for treating a migraine disorder
WO2023091469A1 (en) * 2021-11-17 2023-05-25 The Board Of Trustees Of The Leland Stanford Junior University Targeting periosteal tissue for delivery of therapeutics
WO2024112924A2 (en) * 2022-11-22 2024-05-30 AEON Biopharma, Inc. Optimization of botulinum toxin treatment of migraine and other headache disorders

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA962933A (en) 1969-12-05 1975-02-18 Yutaka Hori Metal foil-plastic laminated film and method of producing the same
US5437291A (en) 1993-08-26 1995-08-01 Univ Johns Hopkins Method for treating gastrointestinal muscle disorders and other smooth muscle dysfunction
US6974578B1 (en) 1993-12-28 2005-12-13 Allergan, Inc. Method for treating secretions and glands using botulinum toxin
US5766605A (en) 1994-04-15 1998-06-16 Mount Sinai School Of Medicine Of The City University Of New York Treatment of autonomic nerve dysfunction with botulinum toxin
US5670484A (en) 1994-05-09 1997-09-23 Binder; William J. Method for treatment of skin lesions associated with cutaneous cell-proliferative disorders
ES2238969T3 (es) * 1994-05-09 2005-09-16 William J. Binder Neurotoxinas presinapticas para el tratamiento de cefaleas migrañosas.
GB9508204D0 (en) 1995-04-21 1995-06-07 Speywood Lab Ltd A novel agent able to modify peripheral afferent function
US6063768A (en) 1997-09-04 2000-05-16 First; Eric R. Application of botulinum toxin to the management of neurogenic inflammatory disorders
CN1324246A (zh) 1998-10-27 2001-11-28 梅约医学教育与研究基金会 增加伤口愈合的方法
US6358917B1 (en) * 1999-08-24 2002-03-19 Jean D. A. Carruthers Cosmetic use of botulinum toxin for treatment of downturned mouth
US6265379B1 (en) 1999-10-13 2001-07-24 Allergan Sales, Inc. Method for treating otic disorders
US6139845A (en) 1999-12-07 2000-10-31 Allergan Sales, Inc. Method for treating cancer with a neurotoxin
US6464986B1 (en) 2000-04-14 2002-10-15 Allegan Sales, Inc. Method for treating pain by peripheral administration of a neurotoxin
US6299893B1 (en) 2000-04-17 2001-10-09 Marvin Schwartz Method to reduce hair loss and stimulate hair regrowth
US6306423B1 (en) 2000-06-02 2001-10-23 Allergan Sales, Inc. Neurotoxin implant
US6423319B1 (en) 2000-10-04 2002-07-23 Allergan Sales, Inc. Methods for treating muscle injuries
US6787517B1 (en) * 2000-12-29 2004-09-07 Allergan, Inc. Agent and methods for treating pain
AU2002355730B2 (en) 2001-07-27 2007-09-13 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Botulinum toxin in the treatment or prevention of acne
US6623742B2 (en) 2001-09-17 2003-09-23 Allergan, Inc. Methods for treating fibromyalgia
DE10150415A1 (de) 2001-10-11 2003-05-15 Andres O Ceballos-Baumann Arzneimittel zur Prophylaxe und Therapie von Depressionen
US20030224019A1 (en) 2002-03-01 2003-12-04 O'brien Christopher Methods of treating nerve entrapment syndromes
US20040009180A1 (en) 2002-07-11 2004-01-15 Allergan, Inc. Transdermal botulinum toxin compositions
US7393537B2 (en) 2003-04-25 2008-07-01 Allergan, Inc. Botulinum toxin for treatment of obsessive compulsive finger biting disorder
US6838434B2 (en) 2003-05-02 2005-01-04 Allergan, Inc. Methods for treating sinus headache
US8734810B2 (en) 2003-10-29 2014-05-27 Allergan, Inc. Botulinum toxin treatments of neurological and neuropsychiatric disorders
US8617572B2 (en) * 2003-10-29 2013-12-31 Allergan, Inc. Botulinum toxin treatments of depression
US20050191321A1 (en) 2004-02-26 2005-09-01 Allergan, Inc. Methods for treating headache
US20100266638A1 (en) * 2004-02-26 2010-10-21 Allergan, Inc. Headache treatment method
US9078892B2 (en) 2004-02-26 2015-07-14 Allergan, Inc. Methods for treating pain and for treating a medication overuse disorder
US7691381B2 (en) * 2004-04-15 2010-04-06 Allergan, Inc. Stabilized biodegradable neurotoxin implants
US7655244B2 (en) 2005-02-01 2010-02-02 Allergan, Inc. Targeted delivery of botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditions
WO2006082339A1 (fr) 2005-02-02 2006-08-10 France Telecom Procede et systeme d'identification par code contextuel
US7910116B2 (en) 2005-08-24 2011-03-22 Allergan, Inc. Use of a botulinum toxin to improve gastric emptying and/or to treat GERD
US8617571B2 (en) * 2008-04-03 2013-12-31 Allergan, Inc. Suture line administration technique using botulinum toxin
CA2745657C (en) * 2008-12-04 2022-06-21 Botulinum Toxin Research Associates, Inc. Extended length botulinum toxin formulation for human or mammalian use
EP2627350A1 (de) * 2010-10-14 2013-08-21 Allergan, Inc. Gezielte abgabe von gezielten exozytosemodulatoren an das ganglion sphenopalatinum zur behandlung von kopfschmerzen
US10111938B2 (en) * 2011-03-30 2018-10-30 Allergan, Inc. Injection paradigm for administration of botulinum toxins
US9764009B2 (en) * 2011-06-13 2017-09-19 Allergan, Inc. Treatment of psychological trauma
US20130236446A1 (en) * 2012-03-12 2013-09-12 William J. Binder Treatment of migraine headache with diffusion of toxin in non-muscle related areas of the mouth
US20150231068A1 (en) * 2012-03-12 2015-08-20 Miotox, Llc Treatment of Migraine Headaches with Presynaptic Neurotoxin
US9068851B2 (en) 2013-01-24 2015-06-30 Sap Se Location and distance based reminders
AU2019299676A1 (en) * 2018-07-05 2021-01-28 Allergan Pharmaceuticals International Limited Combination therapy with CGRP antagonists and Clostridial derivatives

Also Published As

Publication number Publication date
US20090252764A1 (en) 2009-10-08
NZ600858A (en) 2012-12-21
MX2010010885A (es) 2010-11-04
US10220079B2 (en) 2019-03-05
US20190240299A1 (en) 2019-08-08
US9248168B2 (en) 2016-02-02
BRPI0910993A2 (pt) 2015-12-29
ES2372678T3 (es) 2012-01-25
US9827297B2 (en) 2017-11-28
US10874722B2 (en) 2020-12-29
WO2009124046A1 (en) 2009-10-08
US20140079687A1 (en) 2014-03-20
NZ603717A (en) 2014-02-28
US20210121543A1 (en) 2021-04-29
US8617571B2 (en) 2013-12-31
US20180078622A1 (en) 2018-03-22
CA2720112C (en) 2014-09-23
US20230263869A1 (en) 2023-08-24
ES2398904T3 (es) 2013-03-22
EP2392344B1 (de) 2012-12-19
EP2282766B1 (de) 2011-11-02
NZ588648A (en) 2012-11-30
EP2392344A1 (de) 2011-12-07
DK2282766T3 (da) 2012-01-02
EP2282766A1 (de) 2011-02-16
CA2720112A1 (en) 2009-10-08
AU2009231786A1 (en) 2009-10-08
AU2009231786B2 (en) 2015-06-18
US20160151468A1 (en) 2016-06-02
CN102056620A (zh) 2011-05-11

Similar Documents

Publication Publication Date Title
ATE531387T1 (de) Nahtlinien-verabreichungstechnik mit botulinustoxinen
TW200503751A (en) Methods for treating sinus headache
MX2010006731A (es) Uso de un componente neurotoxico de un complejo de toxina de clostridium botulinum para reducir o prevenir efectos secundarios.
DE602004017343D1 (de) Behandlungen mit botulinum toxin von neurologische und neuropsychiatrische krankheiten
BRPI0417493A (pt) terapia com toxina botulìnica para distúrbios da pele
MY153062A (en) Methods of treating gastrointestinal disorders independent of the intake of food
DE602005020309D1 (de) Dehnungsstreifenbehandlung mit botulinumtoxin
AR065033A1 (es) Metodos para prevenir y tratar trastornos neurodegenerativos
DE602006006068D1 (de) Verwendung von botulintoxin zur verbesserung der magenentleerung und/oder behandlung von gerd
WO2009009393A3 (en) Chromium complexes for improvement of memory and cognitive function
WO2009130600A8 (en) Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy
DE602007002625D1 (de) Verwendung von botulintoxin zur linderung von hodenschmerzen
HRP20100208T8 (en) Method of treating acute rhinosinusitis
BRPI0509478A (pt) tratamento de ferida por pressão
WO2010048264A3 (en) Methods and compositions for the treatment of immunoinflammatory disorders
WO2008016665A3 (en) Imidazoacridine compounds for treating flt3 -mediated disorders
WO2006078588A3 (en) Improved methods for treating headache
SI1948216T1 (sl) Zdravljenje akutne ledviäśne odpovedi s topnim trombomodulinom
WO2007105218A3 (en) Composition and method for brain tumor therapy
UA40576U (ru) Способ лечения интрагландулярного лимфаденита околоушной слюнной железы
RU2007136464A (ru) Способ лечения себореи волосистой части головы
RU2004105675A (ru) Способ комплексного лечения язв роговицы
RU2004106376A (ru) Способ лечения хориоретинитов
WO2007134813A3 (en) Use of desmodus salivary plasminogen activator (dspa) for treating venous thromboembolism
UA3548U (uk) Спосіб лікування рухових конверсійних розладів